Evaluation of the Results of Intralesional Bleomycin Injection for Treatment of Haemangioma and Vascular Malformation

Aim: is to evaluate the results of intralesional bleomycin injection for treatment of haemangiomaand vascular malformation. Indications, limitations, adjustment of dose and results of treatment. Patients and Method: This study was carried out on 40 patients with vascular anomalies; either hemangioma or vascular malformations from both sexes at different age groups. Patients treated with intralesional Bleomycin Injection and treatment response will be evaluated. Results: 26 cases (65%) present significant response which includes complete resolution, excellent and good response; 7 cases (17.5%) presents fair response and 7 cases (17.5%) presents poor response. No cases presents no change or increase in size. Conclusion: Intralesional bleomycin injection (IBI) is a simple, practical and noninvasive method of treatment of vascular anomalies and can considered one of priorities in the treatment of Infantile Hemangiomas and small and medium sized venous malformations.